after a change to sulfadoxine-pyrimethamine ( fansidar ; roche ) treatment ( adults 1,500 mg and 75 mg respectively ) these rates fell in march 1988 to 6.9 % and 0.4 % .
C0700599
sulfadoxine-pyrimethamine
C0060061
fansidar